Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
Overdose deaths rose by nearly 5% in 2019, and the pandemic could make matters worse.
Infective endocarditis is a life-threatening bacterial infection of the heart valves that is associated with injection drug use.
The nation’s health care system provides unrestricted access to hepatitis C treatment.
This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.
A survey of local health departments reveals concerning news—and a silver lining.
A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.
Even after federal regulators relaxed rules requiring daily clinic visits, these bad actors are still bringing patients in for monitoring.
The coronavirus pandemic has upended the usual systems governing the dispensation of medication-assisted treatment.
The CDC calls for everyone to be tested and for all pregnant women to be tested during every pregnancy.
Experts are calling for greater flexibility in clinicians’ ability to deliver treatments for opioid use disorder.
One bill would create 1,000 new residency positions for physicians going into addiction treatment medicine.
Novel coronavirus guidance for people who use drugs and for groups that provide syringe services.
A recent analysis found that health care providers missed opportunities to test 90% of such patients.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.